2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-20095
    Methyl 3-amino-2-thiophenecarboxylate
    		99.99%
    Methyl 3-amino-2-thiophenecarboxylate is a drug intermediate for synthesis of various active compounds.
    Methyl 3-amino-2-thiophenecarboxylate
  • HY-75624
    (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
    		99.09%
    (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ((3β)-17-{[(Trifluoromethyl)sulfonyl]oxy}androsta-5,16-dien-3-yl acetate) is a drug intermediate for synthesis of various active compounds.
    (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
  • HY-43475
    Cholic acid impurity 1
    Cholic acid impurity 1 is an impurity of Cholic acid (HY-N0324).
    Cholic acid impurity 1
  • HY-66016
    3-[(2-Fluoro-4-iodophenyl)amino]isonicotinic acid
    3-[(2-Fluoro-4-iodophenyl)amino]isonicotinic acid is a drug intermediate for synthesis of various active compounds.
    3-[(2-Fluoro-4-iodophenyl)amino]isonicotinic acid
  • HY-42513
    5-(1-Methylcyclopropoxy)-1H-indazole
    5-(1-Methylcyclopropoxy)-1H-indazole is a drug intermediate for synthesis of various active compounds.
    5-(1-Methylcyclopropoxy)-1H-indazole
  • HY-WAA0006
    5-(2-Methoxyethyl)-7-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride
    5-(2-Methoxyethyl)-7-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride is a drug intermediate for synthesis of various active compounds.
    5-(2-Methoxyethyl)-7-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride
  • HY-40062
    (R)-1-Boc-3-propylpiperazine
    		99.71%
    (R)-1-Boc-3-propylpiperazine is a drug intermediate for synthesis of various active compounds.
    (R)-1-Boc-3-propylpiperazine
  • HY-WAA0133
    2-(2-Pyrimidinyl)benzoic acid
    2-(2-Pyrimidinyl)benzoic acid is a drug intermediate for synthesis of various active compounds.
    2-(2-Pyrimidinyl)benzoic acid
  • HY-W045799
    rel-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-3a-carboxylic acid
    rel-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-3a-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    rel-2-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrole-3a-carboxylic acid
  • HY-78414
    Ethyl 3-(4-chlorophenyl)propanoate
    		98.32%
    Ethyl 3-(4-chlorophenyl)propanoate (Ethyl p-chlorohydrocinnamate) is a drug intermediate for synthesis of various active compounds.
    Ethyl 3-(4-chlorophenyl)propanoate
  • HY-400601
    tert-Butyl (2-(2-chloro-4-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)ureido)phenethoxy)ethyl)(methyl)carbamate
    tert-Butyl (2-(2-chloro-4-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)ureido)phenethoxy)ethyl)(methyl)carbamate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl (2-(2-chloro-4-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)ureido)phenethoxy)ethyl)(methyl)carbamate
  • HY-43192
    Ho-peg2-(ch2)6-Cl
    Ho-peg2-(ch2)6-Cl (2-(2-((6-Chlorohexyl)oxy)ethoxy)ethan-1-ol) is a drug intermediate for synthesis of various active compounds.
    Ho-peg2-(ch2)6-Cl
  • HY-B1084
    Cinoctramide
    		99.06%
    Cinoctramide is an intermediate of pharmaceutical synthesis. Cinoctramide can be used for the research of autoimmune diseases.
    Cinoctramide
  • HY-B2227BS3
    L-Lactic acid-13C-1 sodium (20% w/w in water)
    		98.7%
    L-Lactic acid-13C1 (L-E-270-13C1) sodium (20% in water) is the 13C-labeled L-Lactic acid sodium (HY-W040233). L-lactate Sodium is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid. L-Lactic acid Sodium has antiproliferative activityy.
    L-Lactic acid-<sup>13</sup>C-1 sodium (20% w/w in water)
  • HY-42338
    Ethyl (2R)-2-acetoxy-3-(2-hydroxyphenyl)propanoate
    		99.82%
    Ethyl (2R)-2-acetoxy-3-(2-hydroxyphenyl)propanoate is a drug intermediate for synthesis of various active compounds.
    Ethyl (2R)-2-acetoxy-3-(2-hydroxyphenyl)propanoate
  • HY-Z0054
    Methyl phenyl sulfone
    		99.73%
    Methyl phenyl sulfone is a drug impurity.
    Methyl phenyl sulfone
  • HY-41633
    (S)-Ethyl 5-((benzyloxy)imino)-2-((tert-butoxycarbonyl)amino)-6-chlorohexanoate
    		98.71%
    (S)-Ethyl 5-((benzyloxy)imino)-2-((tert-butoxycarbonyl)amino)-6-chlorohexanoate is a drug intermediate for synthesis of various active compounds.
    (S)-Ethyl 5-((benzyloxy)imino)-2-((tert-butoxycarbonyl)amino)-6-chlorohexanoate
  • HY-20792
    N-(Benzotriazol-1-ylmethyl)-N-benzyl-1-phenylmethanamine
    N-(Benzotriazol-1-ylmethyl)-N-benzyl-1-phenylmethanamine is a drug intermediate for synthesis of various active compounds.
    N-(Benzotriazol-1-ylmethyl)-N-benzyl-1-phenylmethanamine
  • HY-B1047
    Carsalam
    		99.82%
    Carsalam (Carbonylsalicylamide; 2H-1,3-benzoxazine-2,4-dione) is a salicylamide derivative and precursor compound. Carsalam is a nonsteroidal anti-inflammatory agent and can inhibit platelet aggregation.
    Carsalam
  • HY-W006690
    2-Amino-4-bromo-3-nitropyridine
    2-Amino-4-bromo-3-nitropyridine is a drug intermediate for synthesis of various active compounds.
    2-Amino-4-bromo-3-nitropyridine